Cargando…
A High-Throughput Amenable Dual Luciferase System for Measuring Toxoplasma gondii Bradyzoite Viability after Drug Treatment
[Image: see text] It is estimated that more than 2 billion people are chronically infected with the intracellular protozoan parasite Toxoplasma gondii (T. gondii). Despite this, there is currently no vaccine to prevent infection in humans, and there is no recognized curative treatment to clear tissu...
Autores principales: | Smith, David, Lunghi, Matteo, Olafsson, Einar B., Hatton, Olivia, Di Cristina, Manlio, Carruthers, Vern B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850410/ https://www.ncbi.nlm.nih.gov/pubmed/36548400 http://dx.doi.org/10.1021/acs.analchem.2c02174 |
Ejemplares similares
-
Role of Toxoplasma gondii Chloroquine Resistance Transporter in Bradyzoite Viability and Digestive Vacuole Maintenance
por: Kannan, Geetha, et al.
Publicado: (2019) -
Acquisition of Host Cytosolic Protein by Toxoplasma gondii Bradyzoites
por: Kannan, Geetha, et al.
Publicado: (2021) -
The determinants regulating Toxoplasma gondii bradyzoite development
por: Pan, Ming, et al.
Publicado: (2022) -
Toxoplasma gondii Ingests and Digests Host Cytosolic Proteins
por: Dou, Zhicheng, et al.
Publicado: (2014) -
Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites
por: Murata, Yuho, et al.
Publicado: (2017)